Healthcare Sector
Biotechnology & Drugs Industry 
|
|
|
Data by Company within Biotechnology & Drugs Industry
|
| |
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
| Company |
(Millions) |
(Millions) |
(Millions) |
Number |
| Avalanche Biotechnologies, Inc. |
- |
- |
$ 0 |
- |
| Abbvie Inc. |
$ 138,192 |
$ 26,710 |
$ 6,615 |
26,000 |
| American Bio Medica Corp |
$ 4 |
$ 5 |
$ -1 |
- |
| Acorda Therapeutics Inc |
$ 1,059 |
$ 535 |
$ -43 |
- |
| Aclaris Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Actavis Plc |
- |
- |
$ 0 |
19,200 |
| Ocata Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Adaptimmune Therapeutics Plc |
$ 4,716 |
$ 17 |
$ -76 |
- |
| Fennec Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
| Adma Biologics, Inc. |
$ 55 |
$ 12 |
$ -24 |
- |
| Adverum Biotechnologies, Inc. |
$ 148 |
$ 1 |
$ 34 |
- |
| Aerie Pharmaceuticals Inc |
$ 2,090 |
- |
$ -107 |
- |
| Agenus Inc |
$ 408 |
$ 41 |
$ -116 |
- |
| Allergan Plc |
$ 72,068 |
$ 14,670 |
$ 11,935 |
10,500 |
| Applied Genetic Technologies Corp |
$ 68 |
$ 47 |
$ -1 |
- |
| Alder Biopharmaceuticals Inc |
$ 529 |
- |
$ -259 |
- |
| Alliance Bioenergy Plus, Inc. |
$ 15 |
- |
$ -9 |
- |
| Amarillo Biosciences Inc |
$ 6 |
- |
$ -1 |
- |
| Amarantus Bioscience Holdings, Inc. |
- |
- |
$ 0 |
- |
| Amarantus Bioscience Holdings, Inc. |
- |
- |
$ 0 |
- |
| Amgen Inc. |
$ 137,504 |
$ 23,050 |
$ 8,174 |
17,900 |
| Albany Molecular Research Inc |
$ 928 |
$ 681 |
$ -60 |
- |
| Amyris, Inc. |
$ 78 |
$ 87 |
$ -105 |
440 |
| Aeolus Pharmaceuticals, Inc. |
$ 10 |
$ 1 |
$ -4 |
- |
| Ampliphi Biosciences Corp |
$ 6 |
$ 0 |
$ -23 |
- |
| Aptevo Therapeutics Inc. |
$ 43 |
$ 8 |
$ -8 |
- |
| Ariad Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Arno Therapeutics, Inc |
- |
- |
$ 0 |
- |
| Assembly Biosciences, Inc. |
$ 534 |
- |
$ -51 |
- |
| Asterias Biotherapeutics, Inc. |
$ 158 |
$ 6 |
$ -35 |
- |
| Atara Biotherapeutics, Inc. |
$ 453 |
- |
$ -97 |
- |
| Kubota Pharmaceutical Holdings Co Ltd |
- |
- |
$ 0 |
- |
| Aviragen Therapeutics, Inc. |
$ 28 |
$ 9 |
$ -29 |
- |
| Anavex Life Sciences Corp. |
$ 182 |
$ 0 |
$ -15 |
- |
| Axim Biotechnologies, Inc. |
$ 267 |
$ 0 |
$ -4 |
- |
| Axovant Sciences Ltd. |
$ 2,434 |
- |
$ -212 |
- |
| Aytu Bioscience, Inc |
$ 1 |
$ 3 |
$ -31 |
- |
| Azurrx Biopharma, Inc. |
$ 43 |
- |
$ 0 |
- |
| Brainstorm Cell Therapeutics Inc. |
$ 80 |
- |
$ -5 |
- |
| Biocryst Pharmaceuticals Inc |
$ 436 |
$ 29 |
$ -47 |
- |
| Beesfree, Inc. |
- |
- |
$ 0 |
- |
| U.s. Stem Cell, Inc. |
- |
$ 4 |
$ -4 |
- |
| Premier Biomedical Inc |
$ 4 |
- |
$ -7 |
- |
| Biogen Inc. |
$ 67,465 |
$ 11,717 |
$ 3,288 |
7,550 |
| Immucor Inc |
- |
- |
$ 0 |
- |
| Bluebird Bio, Inc. |
$ 5,460 |
$ 27 |
$ -288 |
- |
| Bionovo Inc |
- |
- |
$ 0 |
- |
| Audentes Therapeutics, Inc. |
$ 675 |
- |
$ -27 |
- |
| Bohai Pharmaceuticals Group, Inc. |
- |
- |
$ 0 |
- |
| Biota Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Biopharmx Corp |
$ 21 |
$ 0 |
$ -18 |
- |
| Biotech Products Services & Research, Inc. |
$ 1 |
$ 0 |
$ -8 |
- |
| Biorestorative Therapies, Inc. |
$ 17 |
$ 0 |
$ -9 |
- |
| Boston Therapeutics, Inc. |
$ 3 |
$ 0 |
$ -4 |
- |
| Biotime Inc |
$ 306 |
$ 4 |
$ 90 |
- |
| Burzynski Research Institute Inc |
$ 7 |
- |
$ -2 |
- |
| Cadence Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| General Cannabis Corp |
$ 40 |
$ 3 |
$ -27 |
- |
| Capricor Therapeutics, Inc. |
$ 29 |
$ 4 |
$ -17 |
- |
| Capstone Therapeutics Corp. |
$ 3 |
- |
$ 1 |
- |
| Casi Pharmaceuticals, Inc. |
$ 61 |
- |
$ 4 |
- |
| Catalyst Biosciences, Inc. |
$ 16 |
$ 1 |
$ -19 |
- |
| Cellular Biomedicine Group, Inc. |
$ 157 |
$ 0 |
$ -29 |
- |
| China Botanic Pharmaceutical |
- |
- |
$ 0 |
- |
| China Biologic Products Holdings, Inc. |
$ 2,501 |
$ 345 |
$ 128 |
- |
| Cellcyte Genetics Corp. |
- |
- |
$ 0 |
- |
| Cidara Therapeutics, Inc. |
$ 117 |
- |
$ -57 |
- |
| Chromadex Corp. |
$ 198 |
$ 20 |
$ -8 |
- |
| Cardax, Inc. |
$ 41 |
$ 0 |
$ -2 |
- |
| Cen Biotech Inc |
- |
- |
$ 0 |
- |
| Cerecor Inc. |
$ 10 |
$ 2 |
$ -13 |
- |
| Compugen Ltd |
$ 179 |
- |
$ 0 |
- |
| Coherus Biosciences, Inc. |
$ 651 |
$ 178 |
$ -117 |
- |
| Chelsea Therapeutics International, Ltd. |
- |
- |
$ 0 |
- |
| China Kangtai Cactus Bio-tech, Inc. |
- |
- |
$ 0 |
- |
| Celladon Corporation |
- |
- |
$ 0 |
- |
| United Cannabis Corp |
$ 45 |
$ 1 |
$ -4 |
- |
| Cannabics Pharmaceuticals Inc. |
- |
- |
$ -1 |
- |
| Compass Biotechnologies Inc. |
- |
- |
$ 0 |
- |
| Cohbar, Inc. |
- |
- |
$ -8 |
- |
| Cocrystal Pharma, Inc. |
$ 207 |
- |
$ -71 |
- |
| Cortex Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Cannapharmarx, Inc. |
- |
- |
$ 0 |
- |
| Curis Inc |
$ 253 |
$ 8 |
$ -70 |
- |
| Crispr Therapeutics Ag |
$ 761 |
- |
$ 0 |
- |
| American Cryostem Corp |
$ 38 |
$ 1 |
$ -1 |
- |
| Champions Oncology, Inc. |
$ 39 |
$ 17 |
$ -5 |
- |
| Ctd Holdings Inc |
$ 29 |
$ 2 |
$ -4 |
6 |
| Cellceutix Corp |
$ 107 |
- |
$ -14 |
- |
| Cytomx Therapeutics, Inc. |
$ 644 |
$ 30 |
$ -62 |
- |
| Citius Pharmaceuticals, Inc. |
$ 16 |
- |
$ -10 |
1 |
| Neuralstem, Inc. |
$ 14 |
$ 0 |
$ -23 |
- |
| Cel Sci Corp |
$ 14 |
- |
$ -10 |
- |
| Cv Sciences, Inc. |
- |
- |
$ -11 |
- |
| Cyanotech Corp |
$ 25 |
$ 34 |
$ 0 |
124 |
| Cytodyn Inc. |
$ 96 |
- |
$ -26 |
- |
| Cytrx Corp |
$ 60 |
- |
$ -45 |
- |
| Dandrit Biotech Usa, Inc. |
$ 38 |
- |
$ -3 |
- |
| Diadexus, Inc. |
- |
- |
$ 0 |
- |
| Diffusion Pharmaceuticals Inc. |
$ 24 |
- |
$ -16 |
- |
| Delmar Pharmaceuticals, Inc. |
- |
- |
$ 0 |
- |
| Dimension Therapeutics, Inc. |
$ 148 |
$ 15 |
$ -53 |
- |
| Dna Testing Centers Corp |
- |
$ 0 |
$ 0 |
- |
| Dendreon Corp |
- |
- |
$ 0 |
- |
| Noho, Inc. |
- |
- |
$ 0 |
- |
| Windtree Therapeutics Inc |
- |
- |
$ 0 |
- |
| Ds Healthcare Group, Inc. |
$ 0 |
$ 12 |
$ -6 |
105 |
| Emergent Biosolutions Inc. |
$ 1,896 |
$ 494 |
$ 74 |
- |
| Edge Therapeutics, Inc. |
$ 287 |
- |
$ -46 |
- |
| Eiger Biopharmaceuticals, Inc. |
$ 97 |
- |
$ 0 |
- |
| Empowered Products, Inc. |
- |
- |
$ 0 |
- |
| Endonovo Therapeutics, Inc. |
$ 9 |
- |
$ -9 |
- |
| Entremed Inc |
- |
- |
$ 0 |
- |
| Entest Biomedical, Inc. |
$ 1 |
- |
$ 0 |
- |
| Enumeral Biomedical Holdings, Inc. |
$ 1 |
$ 2 |
$ -14 |
- |
| Enzon Pharmaceuticals, Inc. |
$ 17 |
$ 11 |
$ 1 |
- |
| Enzymotec Ltd. |
- |
- |
$ 0 |
- |
| Entia Biosciences, Inc. |
$ 0 |
$ 0 |
$ -1 |
- |
| Eastgate Biotech Corp |
- |
- |
$ 0 |
- |
| Fate Therapeutics Inc |
$ 176 |
$ 4 |
$ -36 |
- |
| Fennec Pharmaceuticals Inc. |
$ 126 |
- |
$ -4 |
- |
| Fulgent Genetics, Inc. |
$ 0 |
$ 10 |
$ 0 |
- |
| Foamix Pharmaceuticals Ltd. |
$ 210 |
- |
$ 0 |
68 |
| Global Future City Holding Inc. |
$ 3 |
$ 3 |
$ -5 |
- |
| Galena Biopharma, Inc. |
$ 13 |
- |
$ -33 |
- |
| Gentium S.p.a. |
- |
- |
$ 0 |
- |
| Synageva Biopharma Corp |
- |
- |
$ 0 |
- |
| Gilead Sciences Inc |
$ 108,376 |
$ 27,947 |
$ 11,097 |
7,000 |
| Glucose Health, Inc. |
$ 1 |
- |
$ 0 |
1 |
| Genocea Biosciences, Inc. |
$ 149 |
- |
$ -58 |
- |
| Aevi Genomic Medicine, Inc. |
$ 50 |
- |
$ 0 |
- |
| Green Planet Bio Engineering Co. Ltd. |
- |
- |
$ 0 |
- |
| Green Meadow Products, Inc. |
$ 161 |
$ 0 |
$ 0 |
- |
| Guided Therapeutics Inc |
$ 0 |
$ 0 |
$ -3 |
- |
| Genethera Inc |
- |
- |
$ 0 |
- |
| Gtx Inc |
$ 129 |
- |
$ -26 |
- |
| Gtx Corp |
$ 3 |
$ 1 |
$ -1 |
- |
| Green Vision Biotechnology Corp. |
- |
- |
$ 0 |
- |
| Halozyme Therapeutics Inc. |
$ 2,241 |
$ 134 |
$ -120 |
- |
| Hubei Minkang Pharmaceutical Ltd. |
- |
- |
$ 0 |
- |
| Health Discovery Corp |
- |
- |
$ 0 |
- |
| Hemispherx Biopharma Inc |
$ 9 |
$ 0 |
$ -9 |
- |
| Hedgepath Pharmaceuticals, Inc. |
$ 143 |
- |
$ -9 |
- |
| Hyperion Therapeutics Inc |
- |
- |
$ 0 |
- |
| Heska Corp |
$ 717 |
$ 138 |
$ 15 |
- |
| Hst Global, Inc. |
$ 0 |
- |
$ 0 |
- |
| Idera Pharmaceuticals, Inc. |
$ 333 |
$ 16 |
$ -49 |
- |
| Igi Laboratories, Inc |
- |
- |
$ 0 |
- |
| Intelgenx Technologies Corp. |
$ 47 |
$ 6 |
$ -1 |
- |
| Intellect Neurosciences, Inc. |
- |
- |
$ 0 |
- |
| Immudyne, Inc. |
$ 23 |
$ 5 |
$ -1 |
11 |
| Immage Biotherapeutics Corp. |
- |
- |
$ 0 |
- |
| Immune Therapeutics, Inc. |
$ 10 |
- |
$ -11 |
- |
| Integrated Biopharma Inc |
$ 10 |
$ 47 |
$ 3 |
- |
| Innovus Pharmaceuticals, Inc. |
$ 16 |
$ 8 |
$ -11 |
- |
| Renovacare, Inc. |
- |
- |
$ -3 |
- |
| Jounce Therapeutics, inc. |
$ 363 |
- |
$ 0 |
- |
| Juno Therapeutics, Inc. |
$ 4,667 |
$ 83 |
$ -293 |
- |
| Cadus Corp |
$ 25 |
- |
$ -1 |
- |
| Kite Pharma, Inc. |
$ 10,136 |
$ 32 |
$ -359 |
- |
| Lion Biotechnologies, Inc. |
$ 433 |
- |
$ -67 |
- |
| Lescarden Inc |
- |
- |
$ 0 |
- |
| Atyr Pharma Inc |
$ 92 |
- |
$ -52 |
- |
| Lixte Biotechnology Holdings, Inc. |
$ 6 |
- |
$ -2 |
- |
| La Jolla Pharmaceutical Co |
$ 726 |
- |
$ 0 |
- |
| Lightlake Therapeutics Inc. |
- |
- |
$ 0 |
- |
| Lazuriton Nano Biotechnology (u.s.a.) Inc. |
- |
- |
$ 0 |
- |
| Apollo Endosurgery, inc. |
- |
$ 97 |
$ -52 |
- |
| Mateon Therapeutics Inc |
- |
- |
$ 0 |
- |
| Mabvax Therapeutics Holdings, Inc. |
$ 5 |
- |
$ -26 |
- |
| Multicell Technologies, Inc. |
- |
- |
$ 0 |
- |
| Microchannel Technologies Corp |
- |
- |
$ 0 |
- |
| Medgenics, Inc. |
- |
- |
$ 0 |
- |
| Manhattan Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Mirna Therapeutics, Inc. |
$ 36 |
- |
$ -28 |
- |
| Micromet, Inc. |
- |
- |
$ 0 |
- |
| Mj Pharmaceuticals Inc. |
- |
- |
$ 0 |
- |
| Momenta Pharmaceuticals Inc |
$ 1,244 |
$ 114 |
$ -45 |
- |
| Mount Tam Biotechnologies, Inc. |
$ 6 |
- |
$ -2 |
- |
| Marina Biotech, Inc. |
$ 26 |
- |
$ -4 |
- |
| Mymetics Corp |
- |
$ 1 |
$ -6 |
- |
| Myokardia Inc |
$ 1,395 |
$ 43 |
$ -24 |
- |
| Myrexis, Inc. |
- |
- |
$ 0 |
- |
| Nascent Biotech Inc. |
$ 5 |
- |
$ 0 |
- |
| Neurocrine Biosciences Inc |
$ 4,992 |
- |
$ -220 |
- |
| Caladrius Biosciences, Inc. |
- |
$ 36 |
$ 15 |
- |
| Northsight Capital, Inc. |
- |
$ 0 |
$ -1 |
- |
| Nexus Biopharma Inc |
- |
- |
$ 0 |
- |
| Nantkwest, Inc. |
$ 485 |
$ 0 |
$ -104 |
- |
| Nile Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Nanoantibiotics, Inc. |
- |
- |
$ 0 |
- |
| Nutra Pharma Corp. |
$ 0 |
$ 0 |
$ -4 |
- |
| Nanostring Technologies Inc |
- |
- |
$ 0 |
- |
| Intellia Therapeutics, Inc. |
$ 796 |
$ 23 |
$ -46 |
- |
| Nbty Inc |
- |
- |
$ 0 |
- |
| Nugene International, Inc. |
- |
- |
$ 0 |
8 |
| Nutrastar International Inc. |
- |
- |
$ 0 |
- |
| Novavax Inc |
$ 317 |
$ 21 |
$ -212 |
- |
| N-viro International Corporation |
- |
- |
$ 0 |
- |
| Obalon Therapeutics Inc |
$ 166 |
$ 3 |
$ -15 |
- |
| Oncbiomune Pharmaceuticals, Inc |
$ 12 |
- |
$ -4 |
- |
| Oncocyte Corp |
$ 194 |
- |
$ 0 |
- |
| Spark Therapeutics, Inc. |
$ 2,565 |
$ 20 |
$ -196 |
- |
| Oncobiologics, Inc. |
$ 36 |
- |
$ -7 |
- |
| Organovo Holdings, Inc. |
$ 208 |
$ 4 |
$ -40 |
- |
| Ophthalix, Inc. |
$ 2 |
- |
$ 1 |
- |
| Opiant Pharmaceuticals, Inc. |
$ 56 |
$ 5 |
$ 3 |
- |
| Avant Diagnostics, Inc. |
- |
- |
$ 0 |
- |
| Orgenesis Inc. |
$ 51,669 |
$ 11 |
$ 1 |
- |
| Osiris Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Oncovista Innovative Therapies, Inc |
- |
- |
$ 0 |
- |
| Mateon Therapeutics Inc |
- |
- |
$ -15 |
- |
| Gt Biopharma, Inc. |
$ 0 |
- |
$ -12 |
- |
| Prolor Biotech, Inc. |
- |
- |
$ 0 |
- |
| Procyon Corporation |
- |
$ 4 |
$ 0 |
- |
| Pdl Biopharma, Inc. |
$ 518 |
$ 309 |
$ 131 |
- |
| Quint Media Inc. |
- |
- |
$ 0 |
- |
| Protokinetix, Inc. |
$ 13 |
- |
$ -2 |
- |
| Pulse Biosciences, Inc. |
$ 200 |
$ 0 |
$ -11 |
- |
| Protalix Biotherapeutics, Inc. |
$ 77 |
$ 11 |
$ -80 |
- |
| Pharmacyte Biotech, Inc. |
$ 65 |
- |
$ -5 |
- |
| Proteon Therapeutics Inc |
$ 29 |
- |
$ -26 |
- |
| Pluristem Therapeutics Inc |
$ 137 |
- |
$ -28 |
- |
| Proteo Inc |
- |
$ 0 |
$ 0 |
- |
| Protagonist Therapeutics, Inc |
$ 279 |
- |
$ -22 |
- |
| Proteostasis Therapeutics, Inc. |
$ 47 |
$ 8 |
$ -52 |
- |
| Pulmatrix, Inc. |
$ 38 |
- |
$ -26 |
- |
| Pivot Pharmaceuticals Inc. |
$ 11 |
- |
$ -2 |
- |
| Qiagen Nv |
- |
- |
$ 0 |
- |
| Quint Media Inc. |
- |
- |
$ 0 |
- |
| Rasna Therapeutics Inc. |
- |
- |
$ 0 |
- |
| Rich Pharmaceuticals, Inc. |
$ 0 |
- |
$ -3 |
- |
| Regenocell Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Receptos, Inc. |
- |
- |
$ 0 |
- |
| Ridgefield Acquisition Corp |
- |
- |
$ 0 |
- |
| Restorgenex Corp |
- |
- |
$ 0 |
- |
| Regen Biopharma Inc |
$ 6 |
- |
$ -6 |
- |
| Regado Biosciences Inc |
- |
- |
$ 0 |
- |
| Repligen Corp |
$ 1,616 |
$ 113 |
$ 18 |
- |
| Regenxbio Inc. |
$ 914 |
$ 9 |
$ -74 |
- |
| Regenerx Biopharmaceuticals Inc |
$ 36 |
$ 0 |
$ 2 |
- |
| Relmada Therapeutics, Inc. |
$ 9 |
- |
$ -8 |
- |
| Repros Therapeutics Inc. |
$ 9 |
$ 0 |
$ -16 |
- |
| Respirerx Pharmaceuticals Inc. |
$ 3 |
- |
$ -7 |
- |
| Aytu Bioscience, Inc. |
- |
- |
$ 0 |
- |
| Ruthigen, Inc. |
- |
- |
$ 0 |
- |
| Radient Pharmaceuticals Corp |
- |
- |
$ 0 |
- |
| Strongbridge Biopharma Plc |
$ 253 |
- |
$ -80 |
- |
| Sangui Biotech International Inc |
$ 6 |
$ 0 |
$ 0 |
- |
| Seattle Genetics Inc |
$ 7,553 |
$ 429 |
$ -203 |
- |
| Sangamo Therapeutics, Inc |
$ 1,048 |
$ 19 |
$ -72 |
- |
| Shengtai Pharmaceutical, Inc. |
- |
- |
$ 0 |
- |
| Skinovation Pharmaceutical Inc |
- |
- |
$ 0 |
- |
| Skinvisible Inc |
$ 5 |
$ 0 |
$ -2 |
- |
| Sun Biopharma, Inc. |
$ 37 |
- |
$ -10 |
- |
| Syndax Pharmaceuticals Inc |
$ 231 |
$ 1 |
$ -50 |
- |
| Soligenix, Inc. |
$ 13 |
$ 7 |
$ -6 |
- |
| Senesco Technologies Inc |
- |
- |
$ 0 |
- |
| Senesco Technologies Inc |
- |
- |
$ 0 |
- |
| Microbot Medical Inc. |
- |
- |
$ -7 |
- |
| Sunwin Stevia International, Inc. |
- |
- |
$ 0 |
- |
| Intellicell Biosciences, Inc. |
- |
- |
$ 0 |
- |
| Savient Pharmaceuticals Inc |
- |
- |
$ 0 |
- |
| Sevion Therapeutics, Inc. |
$ 6 |
- |
$ -5 |
- |
| Tobira Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Tracon Pharmaceuticals, Inc. |
$ 62 |
$ 3 |
$ -26 |
- |
| Bio-techne Corp |
$ 4,571 |
$ 563 |
$ 76 |
- |
| Telik Inc |
- |
- |
$ 0 |
- |
| Mabvax Therapeutics Holdings, Inc. |
- |
- |
$ 0 |
- |
| Tongli Pharmaceuticals (usa), Inc. |
- |
- |
$ 0 |
- |
| Tg Therapeutics, Inc. |
$ 744 |
$ 0 |
$ -105 |
- |
| Tg Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Twinlab Consolidated Holdings, Inc. |
$ 233 |
$ 89 |
$ 0 |
- |
| Teligent, Inc. |
$ 368 |
$ 72 |
$ -8 |
- |
| Targeted Medical Pharma, Inc. |
- |
- |
$ 0 |
- |
| Targacept Inc |
- |
- |
$ 0 |
- |
| Trovagene, Inc. |
$ 22 |
$ 0 |
$ -37 |
- |
| Therapeutic Solutions International, Inc. |
$ 9 |
$ 0 |
$ -1 |
- |
| Trius Therapeutics Inc |
- |
- |
$ 0 |
- |
| Taxus Pharmaceuticals Holdings, Inc. |
- |
- |
$ 0 |
- |
| Tyme Technologies, Inc. |
$ 340 |
- |
$ -15 |
- |
| Uluru Inc. |
$ 4 |
$ 0 |
$ -4 |
- |
| United Bancshares Inc |
- |
- |
$ 0 |
- |
| Vitality Biopharma, Inc. |
$ 34 |
$ 0 |
$ -1 |
- |
| Vericel Corp |
$ 159 |
$ 54 |
$ -25 |
- |
| Vical Inc |
$ 27 |
$ 12 |
$ -11 |
- |
| Viropharma Inc |
- |
- |
$ 0 |
- |
| Vistagen Therapeutics, Inc. |
- |
- |
$ -10 |
- |
| Vistagen Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Ventrus Biosciences Inc |
- |
- |
$ 0 |
- |
| Voyager Therapeutics, Inc. |
$ 450 |
$ 8 |
$ 21 |
- |
| Warner Chilcott Plc |
- |
- |
$ 0 |
- |
| Windtree Therapeutics Inc |
$ 2 |
$ 1 |
$ -5 |
- |
| Weikang Bio-technology Group Co., Inc. |
- |
- |
$ 0 |
- |
| Wave Life Sciences Ltd. |
$ 566 |
$ 2 |
$ -69 |
- |
| Xenetic Biosciences, Inc. |
$ 23 |
- |
$ -13 |
- |
| Acceleron Pharma Inc |
$ 1,521 |
$ 13 |
$ -95 |
- |
| Xstelos Holdings, Inc. |
- |
- |
$ 0 |
- |
| Biotechnology & Drugs Industry |
$ 661,274 |
$ 109,342 |
$ 35,751 |
88,914 |
| Earnings |
|
Earnings |
|
Earnings |
|
Earnings Outlook increase
Looking into earnings estimates within the Biotechnology & Drugs Industry in the current quarter, 33.33 % of companies, who provide earning guidance within Biotechnology & Drugs Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates. |
Earnings Guidance unchanged
In the same quarter, none of those companies, who issued earnings outlook, has reiterated its earnings estimates within the Biotechnology & Drugs Industry. |
Earnings Estimates
decrease
Pessimism dominates within Biotechnology & Drugs Industry, as most of the businesses cut their earnings guidance, staggering 66.67 % have revised down earnings outlook. Overall earnings expectations for the Biotechnology & Drugs Industry were cut by %, to the annual earnings expectation of %. |
|
Expected
Eps Growth |
|
|
Eps
Expectation Revision |
|
 |
% Industry
Expected EPS Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Earnings Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
Revenue |
|
Revenue |
|
Revenue |
Sales Forecast increase
In the current quarter 66.67 % of companies, who have issued revenue expectation within Biotechnology & Drugs Industry, have expressed their optimism, by increasing revenue outlook for the current fiscal year. |
Sales Expectations unchanged
Among companies who provide sales guidance within Biotechnology & Drugs Industry 33.33 %, have reiterated own sales estimates for the current fiscal year. |
Sales Outlook decrease
In Biotechnology & Drugs Industry, there were no sales guidance decreases |
|
Expected
Revenue Growth |
|
|
Revenue
Expectation Revision |
|
|
|
% Industry
Expected Revenue Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Revenue Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
| Cardiovascular Segment |
| Revenues |
Income |
|
24.1% |
-16.78% |
377.7% |
-84.61% |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Neuroscience Segment |
| Revenues |
Income |
|
24.1% |
-16.78% |
377.7% |
-84.61% |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Anti-Infective Segment |
| Revenues |
Income |
|
14.75% |
-7.45% |
23.14% |
-12.12% |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
| Respiratory Segment |
| Revenues |
Income |
|
24.1% |
-16.78% |
377.7% |
-84.61% |
| Y/Y |
Q/Q |
Y/Y |
Q/Q |
|
|
